Symbiotix Biotherapies, Inc.

Brookline, MA 02445

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $4.96MM
First Award Date 03/01/14
Most Recent Award Date 09/01/16

Key Personnel

Last Name Name Awards Contact
KASPER LLOYD H KASPER 2
MAZMANIAN SARKIS K MAZMANIAN 2

4 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-15-270
Budget: 09/01/16 - 08/31/17

PROJECT SUMMARY / ABSTRACT Interactions between the gut microbiome and the immune system have been linked to inflammatory bowel disease (IBD). IBD is a chronic and progressive gastrointestinal disease characterized by uncontrolled activation of the intestinal immune system resulting in severe medical complications, affecting over 1.5 million pat...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-14-072
Budget: 06/01/15 - 05/31/16

DESCRIPTION (provided by applicant): Multiple sclerosis (MS) is a chronic demyelinating inflammatory disease that is the most common neurological disease of young adults, affecting over 450,000 patients in the US and over 3.5 million patients worldwide. MS is a disease of high unmet medical need, currently treatable with one of twelve FDA approv...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-13-235
Budget: 07/15/14 - 06/30/15

DESCRIPTION (provided by applicant): Interactions between the gut microbiome and the immune system have been linked to inflammatory bowel disease (IBD). IBD is a chronic and progressive gastrointestinal disease characterized by uncontrolled activation of the intestinal immune system resulting in severe medical complications, affecting over 1.5 m...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-13-089
Budget: 03/01/14 - 02/28/15

Abstract Multiple sclerosis (MS) is a chronic demyelinating inflammatory disease that is the most common neurological disease of young adults, affecting over 350,000 patients in the US and over 2.5 million patients worldwide. MS is a disease of high unmet medical need, currently treatable with one of several approved drugs, all of which result i...